78 related articles for article (PubMed ID: 10703829)
1. Renal side-effects of cyclo-oxygenase-type-2 inhibitor use.
Stubanus M; Riegger GA; Kammerl MC; Fischereder M; Krämer BK
Lancet; 2000 Feb; 355(9205):753. PubMed ID: 10703829
[No Abstract] [Full Text] [Related]
2. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
Knight S; Johns EJ
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
[TBL] [Abstract][Full Text] [Related]
3. Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease.
LeLorier J; Bombardier C; Burgess E; Moist L; Wright N; Cartier P; Huckell V; Hunt R; Nawar T; Tobe S
Can J Cardiol; 2002 Dec; 18(12):1301-8. PubMed ID: 12518182
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
Drago F; Brusati C; Desirello G; Cacciapuoti M; Rebora A
J Am Acad Dermatol; 2004 Dec; 51(6):1029-30. PubMed ID: 15583611
[No Abstract] [Full Text] [Related]
5. Renal effects of cyclo-oxygenase-type-2 inhibition.
Krämer BK
Lancet; 2000 Jan; 355(9199):236-7. PubMed ID: 10675151
[No Abstract] [Full Text] [Related]
6. COX-1 sparing and COX-2 inhibitory drugs: the renal and hepatic safety and tolerability profiles of celecoxib.
Whelton A
Am J Ther; 2000 May; 7(3):151-2. PubMed ID: 11317163
[No Abstract] [Full Text] [Related]
7. Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic.
Peruzzi L; Gianoglio B; Porcellini MG; Coppo R
Lancet; 1999 Nov; 354(9190):1615. PubMed ID: 10560684
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal antiinflammatory drugs, prostaglandins, and the kidney.
Rubin SI
J Am Vet Med Assoc; 1986 May; 188(9):1065-8. PubMed ID: 3086264
[No Abstract] [Full Text] [Related]
9. Leukotrienes, but not angiotensin II, are involved in the renal effects elicited by the prolonged cyclooxygenase-2 inhibition when sodium intake is low.
Salazar F; Salazar FJ; Saez F; Reverte V; Zweifel B; Dufield D; Radabaugh M; Graneto M; Llinas MT; Masferrer JL
J Cardiovasc Pharmacol; 2013 Apr; 61(4):329-36. PubMed ID: 23288201
[TBL] [Abstract][Full Text] [Related]
10. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.
Schwartz JI; Vandormael K; Malice MP; Kalyani RN; Lasseter KC; Holmes GB; Gertz BJ; Gottesdiener KM; Laurenzi M; Redfern KJ; Brune K
Clin Pharmacol Ther; 2002 Jul; 72(1):50-61. PubMed ID: 12152004
[TBL] [Abstract][Full Text] [Related]
11. [Cox-2 inhibitor in renal function].
García RE
Rev Med Chil; 2000 Oct; 128(10):1177-8. PubMed ID: 11357864
[No Abstract] [Full Text] [Related]
12. Evolution of glomerular filtration rate and renal plasma flow in cyclosporine-treated heart transplant recipients over a 1-year period.
Lloveras JJ; Durand D; Ader JL; Tran Van T; Rostaing L; Cerene A; Fournial G; Suc JM
Transplant Proc; 1993 Jun; 25(3):2226. PubMed ID: 8516879
[No Abstract] [Full Text] [Related]
13. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
Osterziel KJ; Nagel F; Dietz R
Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
[TBL] [Abstract][Full Text] [Related]
14. [Immediate effect of the administration of a single dose of gentamicin and cephalothin on renal function].
Seguro AC; Monteiro JL; Rocha Ados S
Rev Hosp Clin Fac Med Sao Paulo; 1988; 43(4):180-5. PubMed ID: 3249888
[No Abstract] [Full Text] [Related]
15. Can the effects of protein restriction on the progression of renal failure also be achieved by pharmacological means?
Verberckmoes R; Van Renterghem Y
Blood Purif; 1989; 7(1):58-60. PubMed ID: 2493259
[TBL] [Abstract][Full Text] [Related]
16. Effects of creatinine, creatol and methylguanidine on renal function.
Yokozawa T; Oura H; Ienaga K; Nakamura K
Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):973-7. PubMed ID: 1479734
[TBL] [Abstract][Full Text] [Related]
17. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.
Packer M
Circulation; 1988 Jun; 77(6 Pt 2):I64-73. PubMed ID: 2967129
[TBL] [Abstract][Full Text] [Related]
18. Side effects of conventional nonsteroidal anti-inflammatory drugs and celecoxib: more similarities than differences.
Stöllberger C; Finsterer J
South Med J; 2004 Feb; 97(2):209. PubMed ID: 14982279
[No Abstract] [Full Text] [Related]
19. Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidney.
Goto F; Jackson EK; Ohnishi A; Herzer W; Branch RA
J Pharmacol Exp Ther; 1987 Dec; 243(3):799-803. PubMed ID: 3121844
[TBL] [Abstract][Full Text] [Related]
20. Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor.
Mohammed S; Croom DW
N Engl J Med; 1999 Jun; 340(25):2005-6. PubMed ID: 10383283
[No Abstract] [Full Text] [Related]
[Next] [New Search]
